Title
Category
Credits
Event date
Cost
Clinical Conversations: Gene Therapy
  • Disease management
  • 0.25 ACPE - Pharmacists
  • 0.25 ACPE - Pharmacy Technicians
  • 0.25 AMA - Physicians
  • 0.25 ANCC - Nurses
  • 0.25 APA - Psychologists
  • 0.25 Attendance - General Attendance
$0.00
This expert interview explores the rapidly evolving role of gene therapy through a practical, clinician‑focused lens. Rather than emphasizing future speculation, the discussion centers on what health care professionals need to know now—how gene-based therapies are entering clinical practice, current understanding of safety and efficacy and the role of clinicians across care settings. By addressing common knowledge gaps between specialists and primary care clinicians and using relatable comparisons to established therapies, the interview highlights the importance of patient education, interdisciplinary communication and timely referral as gene‑based treatments continue to expand.
Clinical Conversations: Fatty Liver Disease
  • Disease management
  • 0.25 ACPE - Pharmacists
  • 0.25 ACPE - Pharmacy Technicians
  • 0.25 AMA - Physicians
  • 0.25 ANCC - Nurses
  • 0.25 APA - Psychologists
  • 0.25 Attendance - General Attendance
$0.00
This expert interview equips clinicians with practical strategies to identify and manage metabolic‑associated fatty liver disease in everyday practice. Emphasizing early detection in an often asymptomatic population, the discussion focuses on using cardiometabolic risk factors and simple, noninvasive tools such as fibrosis 4 (FIB‑4) to stratify risk and guide next steps. By reinforcing a stepwise, team‑based approach to evaluation, referral and evidence‑based management, the interview helps learners translate emerging advances into timely, actionable care for patients at risk.
Gene Therapy in the Genomic Era: Promise, Progress and Patient Impact
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
Gene therapy technologies are revolutionizing treatment for genetic diseases. This session explores the science, clinical applications, and patient perspectives, with a focus on sickle cell disease and emerging technologies like CRISPR.
COPD in 2025: Early Detection, Diagnostic Precision, and Emerging Therapies
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
This session explores the latest updates in the diagnosis and management of chronic obstructive pulmonary disease (COPD) as outlined in the 2025 GOLD Report. Early case finding, refined spirometry protocols and novel therapeutic options are discussed, along with the importance of pre-bronchodilator spirometry, strategies for early detection in at-risk populations, and the integration of new treatments into updated treatment algorithms.
Heart Failure at the Crossroads: Early Recognition and Proactive Management
  • Disease management
  • 1.25 ACPE - Pharmacists
  • 1.25 ACPE - Pharmacy Technicians
  • 1.25 AMA - Physicians
  • 1.25 ANCC - Nurses
  • 1.25 APA - Psychologists
  • 1.25 Attendance - General Attendance
  • 1.25 ASWB - Social Workers
$0.00
Heart failure remains a leading cause of hospitalization and mortality. This session focuses on recognizing early signs, diagnostic tools, and evidence-based strategies to optimize care, improve patient quality of life, and reduce readmissions.
GLP-1 Agonists in Practice: A New Era in Obesity and Diabetes Management
  • Disease management
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
GLP-1 receptor agonists have reshaped the landscape of obesity and type 2 diabetes management, offering benefits beyond glycemic control. This session explores their mechanisms, clinical applications, and emerging evidence on their implications for broader metabolic care and in the treatment of obesity-related conditions such as obstructive sleep apnea.
Optimizing Value in Transplant Candidates with End-Stage Liver Disease with Organ Preservation
  • Disease management
  • 0.50 ACPE - Pharmacists
  • 0.50 ACPE - Pharmacy Technicians
  • 0.50 AMA - Physicians
  • 0.50 ANCC - Nurses
  • 0.50 APA - Psychologists
  • 0.50 Attendance - General Attendance
  • 0.50 CDR - Dietitians
  • 0.50 ASWB - Social Workers
$0.00
Essentials of Oncology and Transplant Management is designed for all who are interested in learning best practices for optimal patient and/or benefit management in the fields of transplant medicine and oncology.
Preventing Veteran Suicide: Strategies and Resources for Community-Based Health Care Professionals
  • Behavioral health
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 ASWB - Social Workers
$0.00
This on-demand webcast will focus on equipping health care professionals with the tools and strategies necessary to support veterans in their communities.
Clinical Conversations: Heart Failure
  • Disease management
  • 0.25 ACPE - Pharmacists
  • 0.25 ACPE - Pharmacy Technicians
  • 0.25 AMA - Physicians
  • 0.25 ANCC - Nurses
  • 0.25 APA - Psychologists
  • 0.25 Attendance - General Attendance
$0.00
This expert interview highlights practical, evidence‑based strategies to improve heart failure outcomes through earlier identification and more effective, team‑based management. Addressing real‑world challenges such as treatment inertia, access to specialty care and medication affordability, the discussion emphasizes the shared role of primary care clinicians, cardiology teams and advanced practice providers in proactive screening and timely titration of guideline‑directed medical therapy. Learners will gain actionable insight into how collaborative care and pragmatic treatment decisions can meaningfully improve patient outcomes.
Perimenopause: Managing Common Challenges
  • Women's health
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity will address updates in evidence-based PM screening strategies, diagnosis, and treatment approaches. It will review the unique challenges faced by women in the perimenopausal stage and discuss the range of physical, emotional, and cognitive symptoms commonly experienced. Participants will be empowered to participate in shared decision-making through improved communication with patients experiencing PM.

Pages